Cannabis has been misunderstood for too long. We are here to change that.
Ganjly was built on a simple belief: people deserve accurate, honest information about cannabis. Not sensationalism. Not fear. Not corporate spin. Just clear, well-researched content that helps real people make informed decisions about their health, their choices, and their rights.
We started this site in 2016 because we saw a gap. Cannabis was becoming legal across the country, millions of people were curious, and most of what was written about it was either breathlessly promotional or hopelessly outdated. We wanted to be something different: a trusted source that takes the subject seriously and respects the intelligence of its readers.
What We Cover
Ganjly covers the full spectrum of cannabis education. That includes the science of how cannabinoids like THC, CBD, CBN, and THCA work in the human body. It includes the legal landscape, which changes constantly and varies dramatically from state to state. It includes practical guides for consumers who want to understand what they are buying, how to dose it, and how to use it safely. And it includes the broader conversation around cannabis policy, medical research, and the communities most affected by decades of prohibition.
We do not have a political agenda. We do not take money from cannabis brands in exchange for favorable coverage. What we publish reflects our editorial judgment, full stop.
Our Editorial Standards
Every article on Ganjly is written with accuracy as the first priority. We cite research where it exists. We are clear about what the evidence supports and what is still emerging. We do not overstate benefits or understate risks. When the science is uncertain, we say so.
We also believe that accessible writing is not the same as dumbed-down writing. Our goal is to take genuinely complex topics, cannabis pharmacology, hemp law, dosing science, and explain them in plain language without losing the nuance. If you finish a Ganjly article and feel more informed than when you started, we have done our job.
Why Cannabis Education Matters
Cannabis is now legal for adult use in nearly half of US states and for medical use in the majority. Tens of millions of Americans use it regularly. Yet the education system, the healthcare system, and mainstream media have been slow to catch up with the reality of legalization.
That gap has real consequences. People use products without understanding what is in them. Patients do not know how to talk to their doctors about cannabis. Consumers in newly legal states do not know their rights. Parents do not know how to have honest conversations with their kids.
Ganjly exists to close that gap. One article at a time, one reader at a time.
What You Will Find Here
We cover cannabis from every angle that matters to real people.
If you are new to cannabis, our beginner guides on THC, CBD, dosing, and consumption methods give you a foundation built on facts rather than assumptions. If you are an experienced user, our deep dives on terpenes, cannabinoids, tolerance, and product categories give you the context to make better choices. If you are a patient or caregiver, our coverage of medical cannabis research and state-by-state program guides gives you practical information you can actually use.
And if you are simply trying to understand what is legal where you live, our state law guides cover every legal state with plain-language breakdowns of possession limits, home growing rights, purchasing rules, and Delta 8 status.
Our Commitment to You
We will always tell you what we know, what we do not know, and where the evidence is still developing. We will update our content when laws change and when new research changes the picture. We will never publish something just because a brand paid us to or because it gets clicks.
Cannabis deserves serious, credible journalism. So do you.
If you have a question, a topic you want us to cover, or feedback on something we got wrong, we want to hear from you. Reach us at wecare@ganjly.com.
Thank you for being part of the Ganjly community.
The Ganjly Team
Trusted Cannabis News Since 2016